| Prostate Cancer Early Detection in the European Union and UK RCA Leenen, LDF Venderbos, J Helleman, JG Rivas, P Vynckier, ... European Urology, 2024 | | 2024 |
| Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry C Bangma, P Doan, L Zhu, S Remmers, D Nieboer, J Helleman, ... European Urology Oncology, 2024 | | 2024 |
| Understanding the barriers to prostate cancer population-based early detection programs: The PRAISE-U BEST survey K Beyer, RCA Leenen, LDF Venderbos, J Helleman, S Remmers, ... Journal of Personalized Medicine 14 (7), 751, 2024 | | 2024 |
| Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer J Dunsmore, E Duncan, SJ MacLennan, J N'Dow, P Cornford, F Esperto, ... BJUI Compass, 2024 | | 2024 |
| Evolution of European prostate cancer screening protocols and summary of ongoing trials MJ van Harten, MJ Roobol, PJ van Leeuwen, PPM Willemse, ... BJU international 134 (1), 31-42, 2024 | | 2024 |
| PIONEER Big Data Platform for Prostate Cancer: Lessons for Advancing Future Real-World Evidence Research A Lawlor, K Beyer, B Russell, C Steinbeisser, A Bjartell, B De Meulder, ... Nature reviews. Urology, 2024 | | 2024 |
| Risk calculators for the detection of prostate cancer: a systematic review FB Denijs, MJ van Harten, JJL Meenderink, RCA Leenen, S Remmers, ... Prostate Cancer and Prostatic Diseases, 1-14, 2024 | 1 | 2024 |
| Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe P Vynckier, L Annemans, S Raes, C Amrouch, P Lindgren, O Májek, ... European Urology, 2024 | 2 | 2024 |
| Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer N Pasanen, K Talala, S Remmers, TLJ Tammela, J Hugosson, MJ Roobol, ... BJU international, 2024 | | 2024 |
| Follow-up on Patients with Initial Negative mpMRI Target and Systematic Biopsy for PI-RADS≥ 3 Lesions–An EAU-YAU Study Enhancing Prostate Cancer Detection. F Zattoni, G Gandaglia, R van den Bergh, G Marra, M Valerio, A Martini, ... | | 2024 |
| MP31-01 OPTIMIZING DETECTION AND PREDICTION OF PROSTATE CANCER AFTER POSITIVE MRI AND NEGATIVE BIOPSIES F Zattoni, G Gandaglia, R van den Bergh, G Marra, M Valerio, J Olivier, ... Journal of Urology 211 (5S), e503, 2024 | | 2024 |
| Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer: A Systematic Review A Lawlor, C Lin, JG Rivas, L Ibáñez, PA López, PP Willemse, MI Omar, ... European Urology Open Science 63, 126-135, 2024 | | 2024 |
| Reply to Borivoj Golijanin, Anthony Mega, and Dragan Golijanin's Letter to the Editor re: Ivo I. de Vos, Sebastiaan Remmers, Renée Hogenhout, Monique J. Roobol, ERSPC Rotterdam … II de Vos, S Remmers, MJ Roobol European urology 85 (5), e142, 2024 | | 2024 |
| Clinical characterization of patients diagnosed with prostate cancer and undergoing conservative management: a PIONEER analysis based on big data G Gandaglia, F Pellegrino, A Golozar, B De Meulder, T Abbott, A Achtman, ... European Urology 85 (5), 457-465, 2024 | 6 | 2024 |
| AGREE II quality assessment of national and international clinical practice guidelines on prostate cancer K Beyer, Y Bhattacharya, C Murray, EJ Smith, R Boissier, A Borkowetz, ... 39th Annual EAU Congress, 2024 | | 2024 |
| OPTIMA Prostate Cancer Care pathways: Bridging Clinical Practice Guidelines, Real World Evidence and Artificial Intelligence to Enhance Decision-Making IA da Costa Santiago, JG Rivas, S MacLennan, K Beyer, C Murray, ... 39th Annual EAU Congress, 2024 | | 2024 |
| Development of prostate cancer typical case presentations and their usage in OPTIMA’s guideline based decision support tool C Murray, K Beyer, G Gandaglia, A Stabile, S Auweter, A Morariu, ... 39th Annual EAU Congress, 2024 | | 2024 |
| How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer? K Beyer, A Lawlor, S Remmers, C Bezuidenhout, JG Rivas, ... European Urology Open Science 62, 1-7, 2024 | | 2024 |
| Comparison of magnetic resonance imaging–based risk calculators to predict prostate cancer risk HD Patel, S Remmers, JL Ellis, EV Li, MJ Roobol, AM Fang, P Davik, ... JAMA Network Open 7 (3), e241516-e241516, 2024 | 3 | 2024 |
| Reasons for discontinuation of active surveillance and subsequent outcome on radical prostatectomy pathology II de Vos, S Remmers, M Graefen, AS Rannikko, C Marenghi, ER Boevé, ... European Urology 85, S1820-S1821, 2024 | | 2024 |
Ewout W. SteyerbergProfessor of Clinical Biostatistics and Medical Decision Making, LUMC & Erasmus MC在 lumc.nl 的电子邮件经过验证
